Time-extended exposure of gastric epithelial cells to secretome of Helicobacter pylori-activated fibroblasts induces reprogramming of gastric epithelium towards pre-cancerogenic and pro-invasive phenotype
- PMID: 35411238
- PMCID: PMC8984895
Time-extended exposure of gastric epithelial cells to secretome of Helicobacter pylori-activated fibroblasts induces reprogramming of gastric epithelium towards pre-cancerogenic and pro-invasive phenotype
Abstract
Despite of the improvement in gastric cancer (GC) therapies patients still suffer from cancer recurrence and metastasis. Recently, the high ratio of these events combined with increased chemoresistance has been related to the asymptomatic Helicobacter pylori (Hp) infections. The limited efficiency of GC treatment strategies is also increasingly attributed to the activity of tumor stroma with the key role of cancer-associated fibroblasts (CAFs). In order to investigate the influence of Hp infection within stromal gastric tissue on cancer initiation and progression, we have exposed normal gastric epithelial cells to long-term influence of Hp-activated gastric fibroblast secretome. We have referred obtained results to this secretome influence on cancer cell lines. The invasive properties of cells were checked by time-lapse video microscopy and basement membrane assays. The expression of invasion-related factors was checked by RT-PCR, Western Blot, immunofluorescence and Elisa. Hp-activated gastric fibroblast secretome induced EMT type 3-related shifts of RGM1 cell phenotype; in particular it augmented their motility, cytoskeletal plasticity and invasiveness. These effects were accompanied by Snail1/Twist activation, the up-regulation of cytokeratin19/FAP/TNC/Integrin-β1 and MMPs, and by the induction of cMethigh/pEGFRhigh phenotype. Mechanistic studies suggest that this microevolution next to TGFβ relies also on c-Met/EGFR signaling interplay and engages HGF-Integrin-Ras-dependent Twist activation leading to MMP and TNC upregulation with subsequent positive auto- and paracrine feedback loops intensifying this process. Similar shifts were detected in cancer cells exposed to this secretome. Collectively, we show that the secretome of Hp-infected fibroblasts induces reprogramming/microevolution of epithelial and cancer cells towards type 3 EMT-related invasive phenotype in a manner reciprocally reliant next to TGFβ on cMet/Integrin-β1/p-EGFR-dependent axis. Apparently, the phenotypical plasticity of Hp-activated fibroblast reprogrammed gastric epithelial cells determines their susceptibility to the pro-invasive signaling, which results in re-organization of gastric niches and provides the cues for GC promotion/progression.
Keywords: Helicobacter pylori-activated fibroblasts; cancer associated fibroblasts; epithelial-mesenchymal transition; epithelial-myofibroblast transition; gastric cancer; mesenchymal-epithelial transition; metastasis.
AJCR Copyright © 2022.
Conflict of interest statement
None.
Figures
Similar articles
-
Helicobacter pylori-activated fibroblasts as a silent partner in gastric cancer development.Cancer Metastasis Rev. 2023 Dec;42(4):1219-1256. doi: 10.1007/s10555-023-10122-1. Epub 2023 Jul 17. Cancer Metastasis Rev. 2023. PMID: 37460910 Free PMC article. Review.
-
Long-Term Helicobacter pylori Infection Switches Gastric Epithelium Reprogramming Towards Cancer Stem Cell-Related Differentiation Program in Hp-Activated Gastric Fibroblast-TGFβ Dependent Manner.Microorganisms. 2020 Oct 2;8(10):1519. doi: 10.3390/microorganisms8101519. Microorganisms. 2020. PMID: 33023180 Free PMC article.
-
Involvement of epithelial-mesenchymal transition-inducing transcription factors in the mechanism of Helicobacter pylori-induced fibroblasts activation.J Physiol Pharmacol. 2019 Oct;70(5). doi: 10.26402/jpp.2019.5.08. Epub 2019 Dec 26. J Physiol Pharmacol. 2019. PMID: 31889044
-
Helicobacter pylori-activated gastric fibroblasts induce epithelial-mesenchymal transition of gastric epithelial cells in vitro in a TGF-β-dependent manner.Helicobacter. 2019 Oct;24(5):e12653. doi: 10.1111/hel.12653. Epub 2019 Aug 14. Helicobacter. 2019. PMID: 31411795
-
Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.J Gastroenterol Hepatol. 2019 Aug;34(8):1287-1295. doi: 10.1111/jgh.14646. Epub 2019 Mar 27. J Gastroenterol Hepatol. 2019. PMID: 30828872 Review.
Cited by
-
Knocking Down HN1 Blocks Helicobacter pylori-Induced Malignant Phenotypes in Gastric Mucosal Cells and Inhibits Gastric Cancer Cell Proliferation, Cytoskeleton Remodeling, and Migration.Biochem Genet. 2024 Mar 25. doi: 10.1007/s10528-024-10731-7. Online ahead of print. Biochem Genet. 2024. PMID: 38526710
-
Helicobacter pylori-activated fibroblasts as a silent partner in gastric cancer development.Cancer Metastasis Rev. 2023 Dec;42(4):1219-1256. doi: 10.1007/s10555-023-10122-1. Epub 2023 Jul 17. Cancer Metastasis Rev. 2023. PMID: 37460910 Free PMC article. Review.
-
Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer.Cells. 2023 Feb 15;12(4):628. doi: 10.3390/cells12040628. Cells. 2023. PMID: 36831295 Free PMC article. Review.
-
Cancer-associated fibroblast related gene signature in Helicobacter pylori-based subtypes of gastric carcinoma for prognosis and tumor microenvironment estimation in silico analysis.Front Med (Lausanne). 2023 Jan 18;10:1079470. doi: 10.3389/fmed.2023.1079470. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36744128 Free PMC article.
-
Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer.Front Immunol. 2022 Oct 20;13:1016817. doi: 10.3389/fimmu.2022.1016817. eCollection 2022. Front Immunol. 2022. PMID: 36341377 Free PMC article. Review.
References
-
- Necchi V, Candusso ME, Tava F, Luinetti O, Ventura U, Fiocca R, Ricci V, Solcia E. Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology. 2007;132:1009–1023. - PubMed
-
- Konturek PC, Konturek SJ, Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis. J Physiol Pharmacol. 2009;60:3–21. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous